Search

Your search keyword '"Blanc, Pierre"' showing total 27 results
Start Over Author "Blanc, Pierre" Publisher springer science and business media llc
27 results on '"Blanc, Pierre"'

7. Diagnosis, Natural History and Treatment of Eosinophilic Enteritis: a Review

Author

Pineton de Chambrun, Guillaume, primary, Dufour, Gaspard, additional, Tassy, Barbara, additional, Rivière, Benjamin, additional, Bouta, Najima, additional, Bismuth, Michael, additional, Panaro, Fabrizio, additional, Funakoshi, Natalie, additional, Ramos, Jeanne, additional, Valats, Jean-Christophe, additional, and Blanc, Pierre, additional

Published
2018
Full Text
View/download PDF

23. Obesity and the Stool Concept

Author

Kassir, Radwan, primary, Blanc, Nadia, additional, Tiffet, Olivier, additional, Lointier, Patrice, additional, Serraille, Gilles, additional, Breton, Christophe, additional, and Blanc, Pierre, additional

Published
2014
Full Text
View/download PDF

27. Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial

Author

Sharshar, Tarek, Porcher, Raphaël, Asfar, Pierre, Grimaldi, Lamiae, Jabot, Julien, Argaud, Laurent, Lebert, Christine, Bollaert, Pierre Édouard, Harlay, Marie Line, Chillet, Patrick, Maury, Éric, Santoli, Francesco, Blanc, Pascal, Sonneville, Romain, Vu, Dinh Chuyen, Rohaut, Benjamin, Mazeraud, Aurélien, Alvarez, Jean Claude, Navarro, Vincent, Clair, Bernard, Outin, Hervé D., Centre Hospitalier Sainte Anne [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Hôpital Hôtel-Dieu [Paris], Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Hôpital Ambroise Paré [AP-HP], Centre hospitalier Félix-Guyon [Saint-Denis, La Réunion], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Lorraine (UL), Hôpital de Hautepierre [Strasbourg], Les Hôpitaux Universitaires de Strasbourg (HUS), Hôpital de Châlons-en-Champagne, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Hôpital Robert Ballanger [Aulnay-sous-Bois], Centre Hospitalier René Dubos [Pontoise], Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier d'Etampes, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Perception et Mémoire / Perception and Memory, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Infection et inflammation (2I), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Raymond Poincaré [Garches], Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy], and Valse investigators and for the Groupe d’Explorations Neurologiques en Reanimation (GENER): Laurent Argaud, Eric Azabou, François Beloncle, Omar Ben-Hadj, Pascal Blanc, Pierre-Edouard Bollaert, Francis Bolgert, Lila Bouadma, Patrick Chillet, Bernard Clair, Philippe Corne, Raphaël Clere-Jehl, Martin Cour, Arielle Crespel, Véronique Déiler, Jean Dellamonica, Sophie Demeret, Marie-Line Harley, Matthieu Henry-Lagarrigue, Julien Jabot, Nicholas Heming, Romain Hernu, Achille Kouatchet, Christine Lebert, Nicolas Lerolle, Eric Maury, Sophie Letrou, Aurélien Mazeraud, Alain Mercat, Satar Mortaza, Bruno Mourvillier, Hervé Outin, Catherine Paugham-Burtz, Marc Pierrot, Marion Provent, Benjamin Rohaut, Sylvie De La Salle, François Santoli, Maleka Schenk, Shidasp Siami, Vincent Souday, Tarek Sharshar, Romain Sonneville, Jean-François Timsit, Marie Thuong, Nicolas Weiss

Subjects
[SDV]Life Sciences [q-bio], Generalised convulsive status epilepticus, Valproic acid, Intensive care unit, Critical Care and Intensive Care Medicine, Seizure
Abstract

Background Generalised convulsive status epilepticus (GCSE) is a medical emergency. Guidelines recommend a stepwise strategy of benzodiazepines followed by a second-line anti-seizure medicine (ASM). However, GCSE is uncontrolled in 20–40% patients and is associated with protracted hospitalisation, disability, and mortality. The objective was to determine whether valproic acid (VPA) as complementary treatment to the stepwise strategy improves the outcomes of patients with de novo established GCSE. Methods This was a multicentre, double-blind, randomised controlled trial in 244 adults admitted to intensive care units for GCSE in 16 French hospitals between 2013 and 2018. Patients received standard care of benzodiazepine and a second-line ASM (except VPA). Intervention patients received a 30 mg/kg VPA loading dose, then a 1 mg/kg/h 12 h infusion, whilst the placebo group received an identical intravenous administration of 0.9% saline as a bolus and continuous infusion. Primary outcome was proportion of patients discharged from hospital by day 15. The secondary outcomes were seizure control, adverse events, and cognition at day 90. Results A total of 126 (52%) and 118 (48%) patients were included in the VPA and placebo groups. 224 (93%) and 227 (93%) received a first-line and a second-line ASM before VPA or placebo infusion. There was no between-group difference for patients hospital-discharged at day 15 [VPA, 77 (61%) versus placebo, 72 (61%), adjusted relative risk 1.04; 95% confidence interval (0.89–1.19); p = 0.58]. There were no between-group differences for secondary outcomes. Conclusions VPA added to the recommended strategy for adult GCSE is well tolerated but did not increase the proportion of patients hospital-discharged by day 15. Trial registration No. NCT01791868 (ClinicalTrials.gov registry), registered: 15 February 2012.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results